Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OrthoSera GmbH

www.orthosera.com

Latest From OrthoSera GmbH

Start-Up Quarterly Statistics, Q4 2015

Start-ups raised $2.41 billion in Q4 2015. Biopharma companies penned 29 alliances; seven acquisitions were signed in the biopharma and diagnostics industries.

BioPharmaceutical Medical Device

Start-Up Execs On The Move, January 2016

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

BioPharmaceutical Medical Device

Medical Device Deals Update, January 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced November-December 2015.

Medical Device Deals

Venture Funding Deals, January 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced November through December 2015.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
    • Biomaterials
  • Therapeutic Areas
  • Dental & Oral Products
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Lacerta Technologies
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Austria
  • Parent & Subsidiaries
  • OrthoSera GmbH
  • Senior Management
  • Zsombor Lacza, MD, PhD, CEO
    Björn Ehring, CFO
  • Contact Info
  • OrthoSera GmbH
    Phone: 664 883 16206
    Dr.-Karl-Dorrek-Straße 23
    Krems an der Donau, 3500
    Austria
Advertisement
Advertisement
UsernamePublicRestriction

Register